
MolMo Services is a molecular modeling and drug design company that provides a wide range of computational and research services for the chemical and pharmaceutical industry. We offer our customers dedicated software for the most demanding challenges in computational chemistry and data-processing. Our modern facility for computational and chemical contract research enables us to respond rapidly to the most complicated problems. MolMo Services also provides targeted and focussed libraries, as in silico data set or as compound collection synthesized through one of our contractors.
From Bioinformatics to Chemical Compounds
MolMo Services provides the link between bioinformatics and molecular biology on one side and the chemical compounds that need to be synthesized to develop new drugs on the other. We are a service oriented company dedicated to providing the best contract research into new targets and lead optimization. MolMo Services will make your own research results more effective by providing the means to synthesize novel drug candidates rapidly and reliably.
Intellectual Property
MolMo Services has since its inception been set up as an intellectual
property provider. Unlike many pharmaceutical consulting and research
companies we do consider the transfer of IP to the customer an
important part of our product offering. This means that our customers
can count on our assistance in protection of the IP we generate for
them, and in the filing of optimal patent applications. But we are
also well aware that IP is more than just the patent: MolMo Services
will provide the externalized knowledge associated with the IP in the
form of reports, presentations, publications, computational methods,
software and software support, and all relevant data to aid you in
managing the know-how generated for your company.
Research by MolMo Services will therefore truly enhance your IP
portfolio and provide a competitive advantage for all your research
driven projects. For some examples of
patents
of our customers see this page.
Cutting Edge Research
The continuing commitment of MolMo Services to innovation is clear from the scientific output: our staff has published more than 50 papers on medicinal chemistry, computational techniques, and many other topics. They also appear as inventors on 20 worldwide patents in disease areas ranging from virology through neurology to oncology. MolMo Services commits a substantial part of its revenues into research projects and innovation. We are for instance involved in international High Performance Computing projects to develop cutting-edge technology for the drug design challenges of the future.